Bradykinin receptors: Towards new pathophysiological roles;Les récepteurs de la bradykinine: De nouveaux rôles physiopathologiques

Medecine/Sciences

Volumn 19, Issue 11, 2003, Pages 1093-1100

  Bascands, Jean Loup ^a   Schanstra, Joost P ^a   Couture, Réjean ^b   Girolami, Jean Pierre ^a  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; BRADYKININ RECEPTOR; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL MODEL; DIABETES MELLITUS; DYSLIPIDEMIA; GLOMERULOSCLEROSIS; HEART FAILURE; HEART FUNCTION; HEART PROTECTION; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KALLIKREIN KININ SYSTEM; KIDNEY FUNCTION; KNOCKOUT MOUSE; MOUSE; NEUROMODULATION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0242497625     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200319111093     Document Type: Review

References (43)

1. Bascands JL, Girolomi JP. La bradykinine. Med Sci 1996; 12: 582-92.
2. 1 receptor for kinins. Pharmacol Rev 1998; 50: 357-86.
3. 1-kinin receptor in cultured human lung fibroblosts. J Clin Invest 1998; 101: 2080-91.
4. Harris B, Ju H, Venema V, et al. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 2001; 276: 16587-91.
5. Duchene J, Schanstra JP, Pecher C, et al. A novel interaction between a G-protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem 2002; 277: 40375-83.
6. AbdAlla S, Lother H, El Massiery A, Quitterer U. Increased AT1 heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001; 7: 1003-9.
7. 2 receptors in the respective control of cell growth and phospholipid hydrolyis. Cancer Res 1992; 52: 334-40.
8. Dixon BS, Dennis MJ. Regulation of mitogenesis by kinins in arterial smooth muscle cells. Am J Physiol 1997; 273: C7-20.
9. Tsuchida S, Miyazaki Y, Matsusaka T, et al. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature. Kidney Int 1999; 56: 509-16.
10. Alric C, Pecher C, Cellier E, et al. Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int 2002; 62: 412-21.
11. Graness A, Hanke S, Boehmer FD, et al. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem J 2000; 347: 441-7.
12. 1 receptor stimulates type I collagen synthesis via stabilization of connective tissue growth factor mRNA. J Biol Chem 2000; 275: 12475-80.
13. Gallagher AH, Yu H, Printz MP. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 1998; 32: 84-8.
14. Wollert KC, Studer R, Doerfer K, et al. Differential effect of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocordium after myocardiol infarction in the rat. Circulation 1997; 95: 1910-17.
15. Silva JA, Araujo RC, Baltatu O, et al. Reduced cardiovascular hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB J 2000; 14: 1858-60.
16. Schanstra JP, Neau E, Drogoz P, et al. In vivo bradykinin receptor activation reduces renal fibrosis. J Clin Invest 2002; 110: 371-9.
17. Sylvestre JB, Bergaya S, Tamarat R, et al. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res 2001; 89: 678-83.
18. 1 receptor for therapeutic neovascularisation. Circulation 2002; 105: 360-6.
19. Volpert OA, Word NF, Lingen MW, et al. Captopril inhibits angiogenesis and slow the growth of experimental tumors in rat. J Clin Invest 1996; 98: 671-9.
20. Meneton P, Bloch-Faure M, Hagege A, et al. Tissue kallikrein is required for normal cardiac function in the mouse. Proc Natl Acad Sci USA 2001; 98: 2634-9.
21. Pinto YS, Bader M, Pesquero JB, et al. Increased kallikrein excretion protects against cardiac ischemia. FASEB J 2000; 14: 1861-3.
22. 2 kinin receptor knock out mice end kininogen-deficient rats. Hypertension 1997; 30: 735-40.
23. 2 BKR receptor polymorphism and left-ventricular growth esponse. Lancet 2001; 358: 1155-6.
24. Linz W, Wiemer G, Golke P, et al. Contributions of kinins to the cardiovascular effect of angiotensin converting enzyme inhibitor. Pharmacol Rev 1995; 47: 25-49.
25. Pesquero JB, Araujo RC, Heppenstall PA, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 2000; 97: 8140-5.
26. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol 1993; 110: 71-6.
27. 1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 2002; 105: 627-32.
28. Witherow FN, Helmy A, Webb DJ, et al. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation 2001; 104: 2177-81.
29. Bralet J, Schwartz JC. Vasopeptidase inhibitors: An emerging class of cardiovascular drugs. Trends Pharmacol Sci 2001; 22: 106-9.
30. Mukae S, Aoki S, Itoh S, et al. Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor related cough. Hypertension 2000; 36: 127-31.
31. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Génétique de la Néphropothie Diabétique (GENEDIAB) study group. J Clin Invest 1997; 99: 385-95.
32. Sharma K, Eltayeb BD, Mc Gowon TA, et al. Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999; 34: 819-23.
33. Henriksen EJ, Jacob S, Augustin HJ, Dietze GJ. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes 2000; 45: S125-8.
34. Haring HU, Tippmer S, Kellerer M, et al. Modulation of insulin receptor signaling. Potential mechanisms of a cross talk between bradykinin and the insulin receptor. Diabetes 1996; 45: S115-9.
35. Carvalho CRO, Thirone ACP, Gontjo JAR, et al. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 1997; 46: 1950-7.
36. Cooper ME. Interaction of metabolic and hoemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001; 44: 1957-72.
37. Cellier E, Mage M, Duchêne J, et al. Bradykinin reduces growth factor-induced glomerular Erk 1/2 phosphorylation. Am J Physiol 2003; 284: F282-92.
38. Huang N, Gallois Y, Bouby N, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA 2001; 98: 13330-4.
39. Munzel T, Keaney JF. Are ACE Inhibitors a «Mogic Bullet» against oxydative stress? Circulation 2001; 104: 1571-4.
40. Cloutier F, Couture R. Pharmacological characterization of the cardiovoscular responses elicited by kinin B1 and B2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br J Pharmacol 2000; 130: 375-85.
41. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2002; 429: 161-76.
42. De Sousa Buck HS, Ongali B, Thibault G, et al. Autorodiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can J Physiol Pharmacol 2002; 80: 249-57.
43. Cloutier F, De Sousa Buck HS, Ongali B, Couture R. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B2 receptors in the spinal cord of spontaneously hypertensive rats. Br J Pharmacol 2002; 135: 1641-54.